Synchronic Duodenal Gastrointestinal Stromal Tumor and Neuroendocrine Tumor in Association with Neurofibromatosis Type 1: A Case Report
- 1 Clinical Oncological Division, Sao Rafael Hospital, Salvador, Bahia, Brazil
- 2 Surgical Oncological Team, Sao Rafael Hospital, Salvador, Bahia, Brazil
- 3 Clinical Oncological Division, Sao Rafael Hospital, Salvador, Bahia, Brazil
- 4 Pathological Division, Sao Rafael Hospital, Salvador, Bahia, Brazil
Abstract
Introduction: The coexistence of synchronic duodenal gastrointestinal stromal tumor (GIST) and neuroendocrine tumor in a patient with neurofibromatosis type 1 (NF1) is extremely rare, and only eight cases were described in the literature. Clinical Case: This is a rare case of a 38-year-old female patient with NF1 who developed synchronic GIST and neuroendocrine tumor, which were both in the second portion of the duodenum. The first symptoms were abrupt digestive bleeding and anemia. Upper digestive endoscopy revealed two tumors, sizes 2.5 and 3.0 cm, in the second portion of duodenum, with biopsies identifying a GIST and a neuroendocrine tumor. Therapeutic decision was to proceed to surgical resection, and Whipple’s procedure was indicated. Surgical procedure was performed with good outcome. Currently the patient has excellent quality of life and maintains follow up for thirty months without recurrence. Discussion: Long-term disease-free survival and excellent quality of life are rep orted when these tumors are fully resected in this context. However, it is not always easy to access the gastrointestinal tract, especially the small intestine, and proceed to the histopathologic diagnosis of these tumors. Conclusion: It is important to be aware of the possibility of the coexistence of various tumors in t he NF1 scenario for adequate screening, staging, and surgical treatment of these patients, as good prognosis can be achieved when such tumors are detected and treated properly.
- Korf, B.R. (2000) Malignancy in Neurofibromatosis Type 1. Oncologist, 5, 477-485. https://doi.org/10.1634/theoncologist.5-6-477
- Riccardi, V.M. (1981) Von Recklinghausen Neurofibromatosis. The New England Journal of Medicine, 305, 1617-1627. https://doi.org/10.1056/NEJM198112313052704
- Behranwala, K.A., Spalding, D., Wotherspoon, A., Fisher, C. and Thompson, J.N. (2004) Small Bowel Gastrointestinal Stromal Tumours and Ampullary Cancer in Type 1 Neurofibromatosis. World Journal of Surgical Oncology, 2, 1. https://doi.org/10.1186/1477-7819-2-1
- Miettinen, M., Fetsch, J.F., Sobin, L.H. and Lasota, J. (2006) Gastrointestinal Stromal Tumors in Patients with Neurofibromatosis 1: A Clinicopathologic and Molecular Genetic Study of 45 Cases. The American Journal of Surgical Pathology, 30, 90-99. https://doi.org/10.1097/01.pas.0000176433.81079.bd
- Zoller, M.E., Rembeck, B., Oden, A., Samuelsson, M. and Angervall, L. (1997) Malignant and Benign Tumors in Patients with Neurofibromatosis Type 1 in a Defined Swedish Population. Cancer, 79, 2125-2131. https://doi.org/10.1002/(SICI)1097-0142(19970601)79:11 3.0.CO;2-N
- Mussi, C., Schildhaus, H.U., Gronchi, A., Wardelmann, E. and Hohenberger, P. (2008) Therapeutic Consequences from Molecular Biology for Gastrointestinal Stromal Tumor Patients Affected by Neurofibromatosis Type 1. Clinical Cancer Research, 14, 4550-4555. https://doi.org/10.1158/1078-0432.CCR-08-0086
- Dayal, Y., Tallberg, K.A., Nunnemacher, G., DeLellis, R.A. and Wolfe, H.J. (1986) Duodenal Carcinoids in Patients with and without Neurofibromatosis. A Comparative Study. The American Journal of Surgical Pathology, 10, 348-357. https://doi.org/10.1097/00000478-198605000-00007
- Anlauf, M., Garbrecht, N., Bauersfeld, J., Schmitt, A., Henopp, T., Komminoth, P., et al. (2007) Hereditary Neuroendocrine Tumors of the Gastroenteropancreatic System. Virchows Arch, 451, S29-S38. https://doi.org/10.1007/s00428-007-0450-3
- Perren, A., Wiesli, P., Schmid, S., Montani, M., Schmitt, A., Schmid, C., et al. (2006) Pancreatic Endocrine Tumors Are a Rare Manifestation of the Neurofibromatosis Type 1 Phenotype: Molecular Analysis of a Malignant Insulinoma in a NF-1 Patient. The American Journal of Surgical Pathology, 30, 1047-1051. https://doi.org/10.1097/00000478-200608000-00018
- Jensen, R.T., Berna, M.J., Bingham, D.B. and Norton, J.A. (2008) Inherited Pancreatic Endocrine Tumor Syndromes: Advances in Molecular Pathogenesis, Diagnosis, Management, and Controversies. Cancer, 113, 1807-1843. https://doi.org/10.1002/cncr.23648